We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications (PREFER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01518101
Recruitment Status : Completed
First Posted : January 25, 2012
Last Update Posted : February 27, 2017
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )